{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:29:52Z","timestamp":1784086192797,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["14000124536"],"award-info":[{"award-number":["14000124536"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biopha.2023.115356","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T17:02:50Z","timestamp":1693846970000},"page":"115356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dimedone nanoparticle as a promising approach against toxoplasmosis: In vitro and in vivo evaluation"],"prefix":"10.1016","volume":"166","author":[{"given":"Seyedmousa","family":"Motavallihaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Maghsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Barati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Soleimani","family":"Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Farmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeze","family":"Foroughi-Parvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115356_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.micpath.2019.01.040","article-title":"Seroprevalence of Toxoplasma gondii infection in cancer patients: a systematic review and meta-analysis","volume":"129","author":"Anvari","year":"2019","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.biopha.2023.115356_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100741","article-title":"Toxoplasmosis and the heart","volume":"46","author":"Zhou","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2023.115356_bib3","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug resistance in Toxoplasma gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115356_bib4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises of parasite three clonal lineages: correlation with human disease genotype","volume":"172","author":"Howe","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115356_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/HAB-180346","article-title":"Detection of Toxoplasma gondii B1 gene in placenta does not prove congenital toxoplasmosis","volume":"27","author":"Sardarian","year":"2019","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.biopha.2023.115356_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/0074-02760150459","article-title":"Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern Brazil","volume":"111","author":"Oliveira","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"4","key":"10.1016\/j.biopha.2023.115356_bib7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.01203-07","article-title":"In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone","volume":"52","author":"Meneceur","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2023.115356_bib8","article-title":"Synthesis of new amino-1, 5-benzodiazepine and benzotriazole derivatives from dimedone","volume":"1","author":"Bennamane","year":"2008","journal-title":"Org. Commun."},{"key":"10.1016\/j.biopha.2023.115356_bib9","first-page":"1","article-title":"Microwave assisted, H3PW12O40 mediated green synthesis, crystal structure, in-vitro anti-inflammatory and anti-oxidant investigation of enaminoketones","author":"Lavanya","year":"2022","journal-title":"Polycycl. Aroma Compd."},{"issue":"12","key":"10.1016\/j.biopha.2023.115356_bib10","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2174\/1871520619666190416102144","article-title":"Synthesis and biological evaluation of novel 4, 5, 6, 7-tetrahydrobenzo [D]-Thiazol-2-Yl derivatives derived from dimedone with anti-tumor, c-met, tyrosine kinase and Pim-1 inhibitions","volume":"19","author":"Mohareb","year":"2019","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.biopha.2023.115356_bib11","unstructured":"S. Finokaliotou, Synthetic and Biological Studies of Antiparasitic Natural Product Derivatives, University of Bath, 2009."},{"key":"10.1016\/j.biopha.2023.115356_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103195","article-title":"Synthesis of new indazole based dual inhibitors of \u03b1-glucosidase and \u03b1-amylase enzymes, their in vitro, in silico and kinetics studies","volume":"94","author":"Rafique","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2023.115356_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00706-018-2157-3","article-title":"Synthesis and investigation of antimicrobial and antioxidant activity of anthraquinonylhydrazones","volume":"149","author":"Stasevych","year":"2018","journal-title":"Monatsh. F\u00fcr Chem."},{"issue":"53","key":"10.1016\/j.biopha.2023.115356_bib14","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1039\/C4CC02279C","article-title":"Chiral squaramide-catalyzed asymmetric synthesis of pyranones and pyranonaphthoquinones via cascade reactions of 1, 3-dicarbonyls with Morita\u2013Baylis\u2013Hillman acetates of nitroalkenes","volume":"50","author":"Nair","year":"2014","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2023.115356_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-018-0399-0","article-title":"Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures","volume":"12","author":"Barakat","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.biopha.2023.115356_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116498","article-title":"Synthesis, characterization, DFT calculation, DNA binding and antimicrobial activities of metal complexes of dimedone arylhydrazone","volume":"334","author":"Abou-Melha","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.biopha.2023.115356_bib17","first-page":"2","article-title":"A three component one-pot synthesis and biological studies of some new octahydroacridine-1, 8-dione derivatives containing tetrazolo [1, 5-a] quinoline moiety","volume":"44","author":"Bhuva","year":"2012","journal-title":"ChemInform"},{"issue":"4","key":"10.1016\/j.biopha.2023.115356_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cbdd.12973","article-title":"One\u2010pot cascade synthesis and in vitro evaluation of anti\u2010inflammatory and antidiabetic activities of S\u2010methylphenyl substituted acridine\u20101, 8\u2013diones","volume":"90","author":"Mallu","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"58","key":"10.1016\/j.biopha.2023.115356_bib19","doi-asserted-by":"crossref","first-page":"35499","DOI":"10.1039\/D0RA06738E","article-title":"Pyridine-2-carboxylic acid as an effectual catalyst for rapid multi-component synthesis of pyrazolo [3, 4-b] quinolinones","volume":"10","author":"Sharma","year":"2020","journal-title":"RSC Adv."},{"issue":"13","key":"10.1016\/j.biopha.2023.115356_bib20","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/slct.201702285","article-title":"Microwave\u2010assisted synthesis of novel pyrazole clubbed polyhydroquinolines in an Ionic\u2010liquid and their biological perspective","volume":"3","author":"Bhatt","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.biopha.2023.115356_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exppara.2018.04.010","article-title":"Anti-Trypanosoma cruzi action of a new benzofuran derivative based on amiodarone structure","volume":"189","author":"Pinto-Martinez","year":"2018","journal-title":"Exp. Parasitol."},{"issue":"13","key":"10.1016\/j.biopha.2023.115356_bib22","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/molecules24132413","article-title":"A comparative study of the anticancer activity and PARP-1 inhibiting effect of benzofuran\u2013pyrazole scaffold and its nano-sized particles in human breast cancer cells","volume":"24","author":"Anwar","year":"2019","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.biopha.2023.115356_bib23","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1016\/j.bmc.2013.07.002","article-title":"Synthesis of polysubstituted benzofuran derivatives as novel inhibitors of parasitic growth","volume":"21","author":"Th\u00e9venin","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2023.115356_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8516498","article-title":"Coprecipitation method of synthesis, characterization, and cytotoxicity of Pr3+: LaF3 (CPr= 3, 7, 12, 20, 30%) nanoparticles","volume":"2018","author":"Pudovkin","year":"2018","journal-title":"J. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115356_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1515\/chem-2019-0100","article-title":"Synthesis of Co3O4 nano aggregates by co-precipitation method and its catalytic and fuel additive applications","volume":"17","author":"Janjua","year":"2019","journal-title":"Open Chem."},{"issue":"4","key":"10.1016\/j.biopha.2023.115356_bib26","first-page":"21","article-title":"Optimization and characterization of primaquineloaded solid lipid nanoparticles (SLN) for liver schinonticide targeting by freeze drying","volume":"1","author":"Owuor","year":"2017","journal-title":"Moj Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2023.115356_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.10.006","article-title":"Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits","volume":"109","author":"Chetoni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115356_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vetpar.2011.12.039","article-title":"Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models","volume":"187","author":"Barbosa","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.biopha.2023.115356_bib29","doi-asserted-by":"crossref","unstructured":"E. \u015eamdanci-T\u00fcrkmen, A. Taylan-\u00d6zkan, C. Bab\u00fcr, M. Mungan, E. Aydin, Evaluation of Systemic Tissue Involvement in Mice following Intraperitoneal Inoculation of Toxoplasma gondii RH Ankara Strain, 2015.","DOI":"10.5505\/TurkHijyen.2015.32448"},{"issue":"7","key":"10.1016\/j.biopha.2023.115356_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07463","article-title":"QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase","volume":"7","author":"Daoui","year":"2021","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.biopha.2023.115356_bib31","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.4314\/tjpr.v14i9.25","article-title":"Dimedone derivative {2-[(4-hydroxy-phenylamino)-methylene]-5, 5-dimethyl-cyclohexane-1, 3-dione} plays an important role in breast cancer treatment","volume":"14","author":"Song","year":"2015","journal-title":"Trop. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115356_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1501\/Vetfak_0000002675","article-title":"Evaluation of oxidative stress, hematological and biochemical parameters during Toxoplasma gondii infection in gerbils","volume":"62","author":"Atmaca","year":"2015","journal-title":"Ank. \u00dcniv Vet. Fak. Derg."},{"issue":"4","key":"10.1016\/j.biopha.2023.115356_bib33","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00436-012-3015-6","article-title":"Oxidative stress and tryptophan degradation pattern of acute Toxoplasma gondii infection in mice","volume":"111","author":"Engin","year":"2012","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115356_bib34","article-title":"Acute toxoplasmosis and antioxidant levels in the liver, kidney and brain of rats","volume":"64","author":"Turkoglu","year":"2018","journal-title":"Ann. Parasitol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115356_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1055\/s-0033-1351287","article-title":"Non-cytotoxic dimedone derivatives: structure, antiradical and UV protective studies","volume":"63","author":"Joshi","year":"2013","journal-title":"Drug Res."},{"issue":"8","key":"10.1016\/j.biopha.2023.115356_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.5672","article-title":"Synthesis and structural characterization of oxovanadium (IV) complexes of dimedone derivatives","volume":"34","author":"Al\u2010Hazmi","year":"2020","journal-title":"Appl. Organomet Chem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:58:39Z","timestamp":1782370719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223011472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":36,"alternative-id":["S0753332223011472"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115356","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimedone nanoparticle as a promising approach against toxoplasmosis: In vitro and in vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115356"}}